Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
06/30/2025
06/30/2024
06/30/2023
06/30/2022
06/30/2021
Revenus
5,398
5,146
4,685
4,222
3,578
3,196
Croissance des revenus (H/H)
10%
10%
11%
18%
12%
8%
Coût des ventes
2,113
2,092
2,029
1,867
1,553
1,352
Bénéfice brut
3,284
3,053
2,655
2,355
2,024
1,844
Vente, Général et Administration
1,048
991
917
874
739
670
Recherche et développement
348
331
307
287
253
225
Frais d'exploitation
1,443
1,367
1,271
1,203
1,024
926
Autres revenus (charges) non opérationnels
-14
-5
-3
-5
3
1
Bénéfice avant impôts
1,818
1,677
1,264
1,101
960
883
Charge d'impôt sur le revenu
332
276
243
204
181
409
Bénéfice net
1,485
1,400
1,020
897
779
474
Croissance du bénéfice net
19%
37%
14%
15%
64%
-24%
Actions en circulation (diluées)
146.37
147.34
147.55
147.45
147.04
146.45
Variation des actions (H-H)
-1%
0%
0%
0%
0%
1%
EPS (dilué)
10.15
9.5
6.91
6.08
5.3
3.24
Croissance du EPS
20%
37%
14%
15%
64%
-24%
Flux de trésorerie libre
1,776
1,650
1,286
559
195
619
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
60.83%
59.32%
56.67%
55.77%
56.56%
57.69%
Marge opérationnelle
34.1%
32.74%
29.54%
27.26%
27.94%
28.69%
Marge bénéficiaire
27.51%
27.2%
21.77%
21.24%
21.77%
14.83%
Marge du flux de trésorerie libre
32.9%
32.06%
27.44%
13.24%
5.44%
19.36%
EBITDA
2,045
1,883
1,560
1,316
1,193
1,073
Marge EBITDA
37.88%
36.59%
33.29%
31.17%
33.34%
33.57%
D&A pour le résultat opérationnel
204
198
176
165
193
156
EBIT
1,841
1,685
1,384
1,151
1,000
917
Marge EBIT
34.1%
32.74%
29.54%
27.26%
27.94%
28.69%
Taux d'imposition effectif
18.26%
16.45%
19.22%
18.52%
18.85%
46.31%
Statistiques clés
Clôture préc.
$28.1
Prix d'ouverture
$29.82
Plage de la journée
$29.82 - $29.82
Plage de 52 semaines
$16.57 - $30
Volume
39
Volume moyen
3.4K
BPA (TTM)
9.77
Rendement en dividend
0.85%
Capitalisation boursière
$4.3B
Qu’est-ce que RSMDF ?
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,600 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.